The GeneSight ADHD test analyzes how your genes affect the way your body may respond to FDA-approved medicines commonly prescribed to treat ADHD. Both adults and children may be diagnosed with ADHD. The information from GeneSight can help healthcare providers select the medicine(s) and dose(s) that are best suited to an individual patient’s condition and genetic makeup. Medicines that align well with a patient’s genes may work better and with fewer side effects.
If you or your child are being treated for ADHD, you know how challenging it can be to get on the right treatment.
GeneSight is based on pharmacogenomics—the study of how genes affect a person’s response to medicines. This test was developed in the Assurex Health clinical laboratory and is based on patented technology licensed from two world renowned medical centers, Mayo Clinic and Cincinnati Children’s Hospital Medical Center, who continue to be research collaborators.
For adolescents, when they’re first presenting for psychiatric treatment, we want all the information we can get to help select the best treatment option for them. GeneSight is an important component in that process.Paul E. Keck, Jr., MD